Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylation

Transplantation

Volumn 90, Issue 4, 2010, Pages 380-386

  Reich Zeliger, Shlomit ^a   Eidelstein, Yaki ^a   Hagin, David ^a   Antebi, Yaron E ^a   Seger, Rony ^a   Reisner, Yair ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apoptosis; Cytotoxic; Experimental

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; LIPOCORTIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; X LINKED INHIBITOR OF APOPTOSIS;

ALLOIMMUNITY; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; INCUBATION TIME; KNOCKOUT MOUSE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE; TRANSPLANTATION TOLERANCE; VETO CYTOTOXIC T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CLONAL DELETION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HISTOCOMPATIBILITY ANTIGENS CLASS I; KINETICS; LYMPHOCYTE DEPLETION; MICE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77955982589     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e86b28     Document Type: Article

References (33)

1. Sambhara SR, Miller RG. Reduction of CTL antipeptide response mediated by CD8+ cells whose class I MHC can bind the peptide. J Immunol 1994; 152: 1103.
2. Cassell D, Forman J. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes. J Immunol 1991; 146: 3.
3. Reich-Zeliger S, Bachar-Lustig E, Gan J, et al. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells. J Immunol 2004; 173: 6654.
4. Reisner Y. Hematopoietic stem cell transplantation across major genetic barriers. Immunol Res 2007; 38: 174.
5. Bachar-Lustig E, Reich-Zeliger S, Reisner Y. Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: Synergism with rapamycin and BM cell dose. Blood 2003; 102: 1943.
6. Reich-Zeliger S, Zhao Y, Krauthgamer R, et al. Anti-third party CD8+ CTLs as potent veto cells: Coexpression of CD8 and FasL is a prerequisite. Immunity 2000; 13: 507.
7. Rich RF, Green WR. Antiretroviral cytolytic T lymphocyte nonrespon-siveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells. J Virol 1999; 73: 3826.
8. Rich RF, Green WR. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells. J Immunol 2002; 168: 2751.
9. Reich-Zeliger S, Gan J, Bachar-Lustig E, et al. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis. J Immunol 2004; 173: 6660.
10. Van Den Brink MR, Kapeller R, Pratt JC, et al. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J Biol Chem 1999; 274: 11178.
11. Zhu L, Yu X, Akatsuka Y, et al. Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells. Immunology 1999; 97: 26.
12. Denault JB, Eckelman BP, Shin H, et al. Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9. Biochem J 2007; 405: 11.
13. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998; 17: 2215.
14. Takahashi R, Deveraux Q, Tamm I, et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 1998; 273: 7787.
15. Roy N, Deveraux QL, Takahashi R, et al. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997; 16: 6914.
16. Jendrossek V, Handrick R, Belka C. Celecoxib activates a novel mito-chondrial apoptosis signaling pathway. FASEB J 2003; 17: 1547.
17. Marsden VS, O'Connor L, O'Reilly LA, et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 2002; 419: 634.
18. Sun XM, Bratton SB, Butterworth M, et al. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J Biol Chem 2002; 277: 11345.
19. Ahmed-Choudhury J, Williams KT, Young LS, et al. CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2. Cell Signal 2006; 18: 456.
20. BenardO, NaorZ, SegerR.Role ofdynamin, Src, and Rasinthe protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone J Biol Chem 2001; 276: 4554.
21. Borovsky Z, Mishan-Eisenberg G, Yaniv E, et al. Serial triggering of T cell receptors results in incremental accumulation of signaling intermediates. J Biol Chem 2002; 277: 21529.
22. Kemp ML, Wille L, Lewis CL, et al. Quantitative network signal combinations downstream of TCR activation can predict IL-2 production response. J Immunol 2007; 178: 4984.
23. Kraus S, Benard O, Naor Z, et al. c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells. J Biol Chem 2003; 278: 32618.
24. Yoon S, Seger R. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 2006; 24: 21.
25. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997; 385: 544.
26. Sutherland CL, Heath AW, Pelech SL, et al. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinasesby CD40 and the B cell antigen receptor. J Immunol 1996; 157: 3381.
27. Tham EL, Mescher MF. Signaling alterations in activation-induced nonresponsive CD8 T cells. J Immunol 2001; 167: 2040.
28. D'Souza WN, Chang CF, Fischer AM, et al. The Erk2 MAPK regulates CD8 T cell proliferation and survival. J Immunol 2008; 181: 7617.
29. Lafont V, Rouot B, Favero J. The Raf-1/mitogen-activated protein ki-nase kinase-1/extracellular signal-regulated-2 signaling pathway as prerequisite for interleukin-2 gene transcription in lectin-stimulated human primary T lymphocytes. Biochem Pharmacol 1998; 55: 319.
30. Fischer AM, Katayama CD, Pages G, et al. The role of erk1 and erk2 in multiple stages of T cell development. Immunity 2005; 23: 431.
31. Tanimoto Y, Kizaki H. Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells. J Biochem 2002; 131: 319.
32. Goillot E, Raingeaud J, Ranger A, et al. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci\USA 1997; 94: 3302.
33. Jindra PT, Jin YP, Jacamo R, et al. MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway. Biochem Biophys Res Commun 2008; 369: 781.